NCT02531542

Brief Summary

Elderly people constitute the largest proportion of emergency room patients, representing 12% of all emergency room admissions. The need for diagnostic tests or therapeutic interventions is much greater in this patient population. Cardiovascular diseases and symptoms represent 12% of the causes for emergency room admission, and patients suffering from cardiovascular disease are those whose emergency room visit lasts longest. The diagnostic approach in the emergency room in elderly patients admitted for acute dypsnoea is complex, and early identification of acute left-sided heart failure (ALSHF) is vital as it has an impact on prognosis. The clinical signs are difficult to interpret, and are non-specific, particularly at the acute phase and in elderly or obese patients. Indeed, some authors have reported up to 50% of diagnostic errors in elderly patients. Measure of the blood concentration of a natriuretic peptide allows a quick diagnosis. However, peptides suffer from several limitations, particularly in situations that are often encountered in elderly patients, such as sepsis, renal failure, acute coronary syndrome, pulmonary embolism, chronic respiratory failure, atrial fibrillation and high body mass index. Diagnostic performance deteriorates with increasing age, and there is a significant increase in this grey-zone in patients aged ≥75 years. In critical situations in elderly patients, assessment of natriuretic peptides serve mainly to rule out a diagnosis of left heart failure. Some authors have suggested using lung ultrasound in the initial work-up of acute respiratory failure, since some specific profiles are known to be related to the presence of interstitial oedema, reflecting impaired left heart function (e.g. presence of B lines). These studies were performed in the context of intensive or critical care, but data are sparse regarding the application of this approach in the emergency room. The hypothesis is that the diagnostic accuracy of a targeted and quick echographic approach, namely the READ method (Rapid Echography for Acute Dyspnoea), comprising targeted lung ultrasound combined with isolated measure of transmitral flow, would be superior to that of NT-proBNP assessment for the diagnosis of ALSHF in elderly patients (≥75 years) admitted to the emergency department.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
461

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 24, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

February 29, 2016

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 27, 2022

Completed
Last Updated

January 17, 2025

Status Verified

January 1, 2025

Enrollment Period

6.8 years

First QC Date

August 12, 2015

Last Update Submit

January 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To demonstrate the superiority of the READ method over assessment of NT-proBNP for the diagnosis of acute left-sided heart failure in patients aged ≥75 years admitted to the emergency department for acute dyspnoea.

    The diagnosis of ALSHF will be established post hoc by two experts based on a specialised echocardiography performed within 7 days after inclusion, or before discharge (whichever occurs first) and on the patient's medical file. The presence of ALSHF using the READ method is defined as presence of diffuse B-lines on lung ultrasound, combined with a restrictive pattern on analysis of transmitral profile. A diagnosis of ALSHF will be retained if the NT-proBNP level is greater than the threshold value of 1800 pg/mL, which is the appropriate threshold for patients aged \>75 years.

    1 day

Secondary Outcomes (3)

  • To evaluate the utility of the combination of the READ method and assessment of NT-proBNP for the diagnosis of ALSHF.

    1 day

  • To assess the potential influence of patients characteristics (age, sex, clinical presentation) on the diagnostic performance of each method of diagnosis (READ and NT-proBNP assessment).

    1 day

  • To evaluate agreement between the results of the READ approach interpreted immediately in the emergency setting, vs deferred evaluation (outside the emergency setting) of the same images by a different operator.

    1 day

Study Arms (1)

READ echography

OTHER
Device: Echocardiography according to the READ method.

Interventions

* Echocardiography will be performed before any therapy is initiated by a fully trained operator, according to the READ method. The results of this ultrasound will not be communicated to the clinician managing the patient in the emergency room. * A blood sample will be taken during the routine work-up for centralized evaluation of NT-proBNP levels.

READ echography

Eligibility Criteria

Age75 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Admission to the Emergency Department Age ≥ 75 years
  • AND criteria of acute dyspnoea:
  • Breathe rate ≥ 25 cycles/minute
  • or PaO2 ≤ 70 mmHg
  • or SpO2 ≤ 92% in room air
  • or PacO2 ≥ 45 mmHg and pH ≤ 7.35 AND Electrocardiogram in sinus rhythm or in atrial fibrillation at admission

You may not qualify if:

  • Shock i.e. : systolic arterial pressure \<90mmHg; or reduction \>40mmHg or \>30% of usual arterial pressure; or Mean Arterial Pressure \<65mmHG.
  • Acute respiratory distress ie : Respiratory rate \>30cpm, use of accessory respiratory muscles, SpO2 \<90% when O2 therapy is required, impaired consciousness,
  • Presence of acute coronary syndrome on the ECG
  • Other obvious etiological diagnosis (pneumothorax, clinical and radiological manifestations of pneumonia)
  • Cardiological or respiratory medicine therapies initiated before the READ approach could be put in place (at patient's home, pre-hospital and/or in the emergency department) i.e.. diuretic, vasoactive drugs (nitrovasodilator, sympathomimetic and cardiotonic drugs, vasodilators and vasoconstrictors); or Continuous Positive Airway Pressure (CPAP); or invasive or non-invasive ventilation.
  • Patient not affiliated to or beneficiary of the French social security system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University Hospital of Clermont-Ferrand

Clermont-Ferrand, Auvergne, 63000, France

Location

University Hospital of Strasbourg

Strasbourg, Grand Est, 67000, France

Location

Centre hospitalier de Pau

Pau, Nouvelle-Aquitaine, 64000, France

Location

University Hospital of Toulouse

Toulouse, Occitanie, 31000, France

Location

Centre Hospitalier de Toulon

Toulon, Provence-Alpes-Côte d'Azur Region, 83000, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2015

First Posted

August 24, 2015

Study Start

February 29, 2016

Primary Completion

December 20, 2022

Study Completion

December 27, 2022

Last Updated

January 17, 2025

Record last verified: 2025-01

Locations